FR09C0037I1 - - Google Patents
Info
- Publication number
- FR09C0037I1 FR09C0037I1 FR09C0037C FR09C0037I1 FR 09C0037 I1 FR09C0037 I1 FR 09C0037I1 FR 09C0037 C FR09C0037 C FR 09C0037C FR 09C0037 I1 FR09C0037 I1 FR 09C0037I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19970042002 | 1997-08-28 | ||
| KR19970042001 | 1997-08-28 | ||
| PCT/KR1998/000259 WO1999011762A1 (en) | 1997-08-28 | 1998-08-25 | An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR09C0037I1 true FR09C0037I1 (en) | 2009-09-25 |
| FR09C0037I2 FR09C0037I2 (en) | 2021-11-05 |
Family
ID=26633032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR09C0037C Active FR09C0037I2 (en) | 1997-08-28 | 2009-08-14 | ATTENUATED, VERO CELL-ADAPTED JAPANESE ENCEPHALITIS VIRUS AND JAPANESE ENCEPHALITIS VACCINE |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6309650B1 (en) |
| EP (2) | EP1025209B1 (en) |
| JP (1) | JP4161017B2 (en) |
| KR (1) | KR100314404B1 (en) |
| CN (1) | CN1142271C (en) |
| AU (1) | AU748730B2 (en) |
| CA (1) | CA2301000C (en) |
| DE (2) | DE69837211T2 (en) |
| DK (2) | DK1604685T3 (en) |
| ES (2) | ES2382946T3 (en) |
| FR (1) | FR09C0037I2 (en) |
| MY (1) | MY129773A (en) |
| NL (1) | NL300391I2 (en) |
| NZ (1) | NZ503522A (en) |
| WO (1) | WO1999011762A1 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000083657A (en) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | Japanese encephalitis virus vaccine |
| KR20010032699A (en) * | 1998-10-05 | 2001-04-25 | 무따이 마사히꼬 | Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same |
| DK2251419T3 (en) * | 1999-04-22 | 2012-07-02 | Us Agriculture | Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142 |
| AU4472801A (en) * | 2000-04-07 | 2001-10-23 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Inactivated japanese B encephalitis vaccine and process for producing the same |
| BR0210628A (en) * | 2001-06-29 | 2004-08-10 | Becton Dickinson Co | Intradermal release of vaccines and genetic therapeutic agents via microcannula |
| JP2007068401A (en) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | West nile virus vaccine |
| EP1718738A2 (en) * | 2004-02-23 | 2006-11-08 | Crucell Holland B.V. | Virus purification methods |
| CN100340596C (en) * | 2004-05-20 | 2007-10-03 | 佛山市顺德区汉达精密电子科技有限公司 | Recovery of polycarbonate / acrylonitrile-butadiene-styrene copolymer and method for reclaiming same |
| ATE412737T1 (en) * | 2005-04-11 | 2008-11-15 | Crucell Holland Bv | VIRUS CLEANING WITH ULTRAFILTRATION |
| US8591916B2 (en) * | 2007-01-31 | 2013-11-26 | Sanofi Pasteur Biologics, Llc | Flavivirus vaccine vector against influenza virus |
| KR20160003301A (en) * | 2007-12-26 | 2016-01-08 | 기타사토 다이이치 산쿄 백신 가부시키가이샤 | Method of producing Japanese encephalitis vaccine stably storable over long time and use of the vaccine |
| KR101507822B1 (en) | 2008-06-04 | 2015-04-24 | 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | Use of inactivated japanese encephalitis virus particle as adjuvant |
| CN102112151A (en) * | 2008-07-30 | 2011-06-29 | 久光制药株式会社 | Microneedle device and method for increasing the response of japanese encephalitis virus antigen with the microneedle device |
| WO2010137036A2 (en) * | 2009-05-25 | 2010-12-02 | Panacea Biotec Ltd | Novel japanese encephalitis vaccine and method of manufacturing the same |
| KR101144993B1 (en) * | 2009-06-18 | 2012-06-27 | 대한민국 | Antigen for high concentrated hemagglutination of porcine japanese encephalitis virus |
| DK2788023T3 (en) | 2011-12-06 | 2016-12-19 | Valneva Austria Gmbh | Aluminum compounds for use in therapeutics and vaccines |
| CN105744952A (en) * | 2013-09-14 | 2016-07-06 | 巴拉特生物技术国际有限公司 | A viral vaccine and methods of manufacture thereof |
| CN105695424B (en) * | 2015-04-01 | 2019-06-14 | 中国食品药品检定研究院 | Adapted strain and its vaccine of the Japanese Encephalitis Vaccine,Live strain SA14-14-2 on human diploid cell 2BS |
| WO2017109225A1 (en) | 2015-12-23 | 2017-06-29 | Valneva Austria Gmbh | Zika virus vaccine |
| US10881723B2 (en) * | 2016-01-15 | 2021-01-05 | Km Biologics Co., Ltd. | Vaccine containing immobilized virus particles |
| WO2017210215A1 (en) | 2016-05-31 | 2017-12-07 | The Government Of The United States Of America As Represented By The Secretary Of The Army | Zika virus vaccine and methods of production |
| JP7301811B2 (en) | 2017-09-21 | 2023-07-03 | ヴァルネヴァ エスイー | Method for Producing a Pharmaceutical Composition Containing the Immunogenic Chikungunya Virus CHIKV-DELTA 5NSP3 |
| CN111511395B (en) | 2017-11-03 | 2024-10-15 | 武田疫苗股份有限公司 | Methods for inactivating Zika virus and for determining completeness of inactivation |
| JP2021505549A (en) | 2017-11-30 | 2021-02-18 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | Dika vaccine and immunogenic composition, and how to use them |
| CN110684747B (en) * | 2018-07-06 | 2024-05-24 | 厦门大学 | Method for inactivating and preserving respiratory syncytial virus |
| SG11202101889PA (en) * | 2018-08-27 | 2021-03-30 | Mican Tech Inc | Method for evaluating anti-infective drugs, vaccines, etc. using immortalized monocytic cells and induced cells |
| EP3895729A1 (en) | 2020-03-01 | 2021-10-20 | Valneva Austria GmbH | Cpg-adjuvanted sars-cov-2 virus vaccine |
| WO2021176434A1 (en) | 2020-03-01 | 2021-09-10 | Valneva Austria Gmbh | Cpg-adjuvanted sars-cov-2 virus vaccine |
| WO2021204825A2 (en) | 2020-04-06 | 2021-10-14 | Valneva Austria Gmbh | INACTIVATED SARS-CoV-2 VIRUS VACCINE |
| WO2023148256A1 (en) | 2022-02-02 | 2023-08-10 | Valneva Austria Gmbh | Inactivated sars-cov-2 virus vaccine |
| WO2024153686A1 (en) | 2023-01-18 | 2024-07-25 | Valneva Austria Gmbh | Process for virus production in a bioreactor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2704258B2 (en) * | 1987-10-31 | 1998-01-26 | 日本臓器製薬株式会社 | Recombinant vaccinia virus |
| GB8821656D0 (en) * | 1988-09-15 | 1988-10-12 | Health Lab Service Board | Pharmaceutical compositions for eliciting immunostimulant effect |
| JPH085803B2 (en) * | 1988-11-10 | 1996-01-24 | 武田薬品工業株式会社 | Japanese encephalitis vaccine manufacturing method |
| EP0562136A1 (en) | 1992-03-24 | 1993-09-29 | Division Of Microbiology, Kyoto Biken Laboratories, Inc. | Live vaccine to getah virus infectious disease, and trivalent live vaccine to Japanese encephalitis virus, porcine parvovirus and getah virus infectious diseases |
| US6010894A (en) * | 1997-06-13 | 2000-01-04 | Research Development Foundation | Method of screening for attenuating viruses |
-
1998
- 1998-08-25 CN CNB988097974A patent/CN1142271C/en not_active Expired - Lifetime
- 1998-08-25 EP EP98941885A patent/EP1025209B1/en not_active Expired - Lifetime
- 1998-08-25 WO PCT/KR1998/000259 patent/WO1999011762A1/en active IP Right Grant
- 1998-08-25 DK DK05014317.1T patent/DK1604685T3/en active
- 1998-08-25 NZ NZ503522A patent/NZ503522A/en not_active IP Right Cessation
- 1998-08-25 US US09/486,392 patent/US6309650B1/en not_active Expired - Lifetime
- 1998-08-25 AU AU90047/98A patent/AU748730B2/en not_active Expired
- 1998-08-25 ES ES05014317T patent/ES2382946T3/en not_active Expired - Lifetime
- 1998-08-25 EP EP05014317A patent/EP1604685B1/en not_active Expired - Lifetime
- 1998-08-25 ES ES98941885T patent/ES2281929T3/en not_active Expired - Lifetime
- 1998-08-25 CA CA002301000A patent/CA2301000C/en not_active Expired - Lifetime
- 1998-08-25 DE DE69837211T patent/DE69837211T2/en not_active Expired - Lifetime
- 1998-08-25 DK DK98941885T patent/DK1025209T3/en active
- 1998-08-25 JP JP2000508774A patent/JP4161017B2/en not_active Expired - Lifetime
- 1998-08-25 DE DE122009000037C patent/DE122009000037I2/en active Active
- 1998-08-26 MY MYPI98003899A patent/MY129773A/en unknown
- 1998-08-27 KR KR1019980035007A patent/KR100314404B1/en not_active IP Right Cessation
-
2009
- 2009-06-10 NL NL300391C patent/NL300391I2/en unknown
- 2009-08-14 FR FR09C0037C patent/FR09C0037I2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| NZ503522A (en) | 2001-06-29 |
| EP1604685B1 (en) | 2012-02-22 |
| NL300391I1 (en) | 2009-08-03 |
| EP1025209B1 (en) | 2007-02-28 |
| AU9004798A (en) | 1999-03-22 |
| ES2382946T3 (en) | 2012-06-14 |
| JP4161017B2 (en) | 2008-10-08 |
| MY129773A (en) | 2007-04-30 |
| CN1272879A (en) | 2000-11-08 |
| DE122009000037I2 (en) | 2011-06-16 |
| EP1025209A1 (en) | 2000-08-09 |
| EP1604685A3 (en) | 2006-07-05 |
| CA2301000C (en) | 2003-07-08 |
| DK1025209T3 (en) | 2007-06-25 |
| DE69837211T2 (en) | 2007-12-06 |
| EP1604685A2 (en) | 2005-12-14 |
| CN1142271C (en) | 2004-03-17 |
| KR19990023955A (en) | 1999-03-25 |
| FR09C0037I2 (en) | 2021-11-05 |
| KR100314404B1 (en) | 2002-10-12 |
| US6309650B1 (en) | 2001-10-30 |
| DK1604685T3 (en) | 2012-06-18 |
| DE122009000037I1 (en) | 2009-11-05 |
| NL300391I2 (en) | 2009-11-02 |
| DE69837211D1 (en) | 2007-04-12 |
| WO1999011762A1 (en) | 1999-03-11 |
| CA2301000A1 (en) | 1999-03-11 |
| AU748730B2 (en) | 2002-06-13 |
| JP2001514844A (en) | 2001-09-18 |
| ES2281929T3 (en) | 2007-10-01 |